Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
Myriam Chalabi, Andrés F. Cardona, Deepti R. Nagarkar, Arianna Scala, David R. Gandara, Achim Rittmeyer, Matthew L. Albert, Thomas Powles, Marleen Kok, Fernanda Herrera
Topics & Concepts
MedicineAtezolizumabInternal medicineDocetaxelHazard ratioLung cancerOncologyPopulationChemotherapyRandomized controlled trialAntibioticsCancerConfidence intervalImmunotherapyPembrolizumabMicrobiologyBiologyEnvironmental healthCancer Immunotherapy and BiomarkersGut microbiota and healthATP Synthase and ATPases Research